Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,337 public trials 2,831 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan

NCT05286229

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • National Cancer Center Hospital East /ID# 240943 Kashiwa-shi, Chiba, Japan
  • Hokkaido University Hospital /ID# 242672 Sapporo, Hokkaido, Japan
  • Kanazawa University Hospital /ID# 240948 Kanazawa, Ishikawa-ken, Japan
  • Duplicate_Okayama Medical Center /ID# 240949 Okayama, Okayama-ken, Japan
View Trial Details
Active, Not Recruiting

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

NCT01461837

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
  • Children's Hospital and Research Center Oakland Oakland, California, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • Washington University/St. Louis Children's Hospital St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

NCT05210790

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Palo Verde Hematology-Oncology Glendale, Arizona, United States
  • City of Hope Medical Center, Duarte Duarte, California, United States
  • California Cancer Associates for Research and Excellence - Fresno Fresno, California, United States
View all 184 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03190278

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions